| Cat. No. |
Product Name |
Information |
| PC-62303 |
HER2-IN-2
HER2 inhibitor
|
HER2-IN-2 is a potent, selective HER2 inhibitor, only shows potent inhibition for EGFR and Abl in a panel of kinases. |
| PC-62121 |
Theliatinib
EGFR inhibitor
|
Theliatinib (HMPL309) is a highly selective, potent, ATP-competitive inhibitor of EGFR with IC50 of 3 nM/22 nM for EGFR/EGFRT790M/L858R mutant, respectively. |
| PC-61769 |
SKLB188
EGFR inhibitor
|
SKLB188 is a small molecule multikinase inhibitor and potently inhibits EGFR with IC50 of 5 nM. |
| PC-61597 |
CK-101
|
CK-101 (Olafertinib, RX-518) is a novel potent, mutant-selective, irreversible, orally available EGFR inhibitor, overcomes T790M-mediated resistance in NSCLC. |
| PC-61450 |
Avitinib maleate
|
Avitinib maleate (AC-0010MA, AC0010 maleate) is an orally available, irreversible, and mutant-selective EGFR inhibitor with IC50 of 0.18 nM against EGFR L858R/T790M. |
| PC-61449 |
Avitinib
|
Avitinib (Abivertinib, AC-0010, AC0010) is an orally available, irreversible, and mutant-selective EGFR inhibitor with IC50 of 0.18 nM against EGFR L858R/T790M. |
| PC-60919 |
GNS-1481
mutant EGFR inhibitor
|
A novel potent, irreversible, T790M mutant-selective inhibitor of mutant EGFR with IC50 of 6.2, 3.4 and 4.2 nM for L858R-T790M, T790M and Del19-T790M, respectively. |
| PC-60918 |
GNS-1486
EGFR inhibitor
|
GNS-1486 is a novel potent, irreversible, T790M mutant-selective inhibitor of mutant EGFR with IC50 of 8.3, 4.2 and 4.3 nM for L858R-T790M, T790M and Del19-T790M, respectively. |
| PC-60540 |
FD5180
|
FD5180 is a novel protein kinase affinity probe, expands the utility of kinobeads by broadening the kinome coverage for bead-based pull-down. |
| PC-60519 |
Lazertinib
EGFR inhibitor
|
Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations. |
| PC-60296 |
PF-06459988
|
PF-06459988 (PF06459988, PF 6459988) is a potent, selective, irreversible EGFR mutants with IC50 of 13, 7, 21 and 90 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively. |
| PC-60295 |
PF-06747775
|
Mavelertinib (PF-06747775) is a potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively. |
